Accessibility
Contact
Helping people suffering from sight loss
Advancing gene therapies with precision, innovation, and a commitment to addressing ophthalmic diseases that cause significant sight loss
Our aim is to create a better treatment for patients suffering from AMD
At Ikarovec, we are dedicated to developing superior treatments for patients with AMD. Our bi-functional gene therapies deliver multiple synergistic therapeutic proteins directly to the eye, offering a groundbreaking approach to treating a range of ophthalmic disorders.
The Problem
AMD is a devastating eye condition affecting millions of people globally that can lead to blindness and has no effective long-term solution.
Our Solution
Our gene therapy approach targets multiple aspects of the disease pathology thereby improving efficacy and preventing blindness with a safe and effective one-time treatment.
